Author

Peter N. Wiklund

Icahn School of Medicine at Mount SinaiORCID 0000-0001-6497-4697Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Adam M. FarkasiD· 1 shared Amir HorowitziD· 1 shared Austin HakeiD· 1 shared Eric E. SchadtiD· 1 shared Güray AktürkiD· 1 shared John P. SfakianosiD· 1 shared Jun ZhuiD· 1 shared Keziban Ünsal-KaçmaziD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adam M. FarkasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing

Li Wang, John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra, Adam M. Farkas, Sacha Gnjatic, Austin Hake, Sudeh Izadmehr, Peter N. Wiklund, William K. Oh, Péter Márton Szabó, Megan Wind‐Rotolo, Keziban Ünsal-Kaçmaz, , Matthew D. Galsky

The paper identifies proinflammatory monocytes/macrophages associated with resistance to PD-1/PD-L1 blockade in urothelial cancer using bulk and single-cell RNA sequencing.

Clinical Cancer Research · Apr 9, 2021Peer-reviewedGenomics